UnitedHealth Group (NYSE:UNH) Price Target Lowered to $361.00 at Royal Bank Of Canada

UnitedHealth Group (NYSE:UNH) had its price objective decreased by Royal Bank Of Canada from $408.00 to $361.00 in a report published on Wednesday morning,Benzinga reports. Royal Bank Of Canada currently has an outperform rating on the healthcare conglomerate’s stock.

Several other equities analysts have also commented on UNH. Bank of America upped their price objective on shares of UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a report on Wednesday, October 8th. Mizuho lifted their price objective on UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a research note on Thursday, October 9th. Wells Fargo & Company raised their target price on UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a report on Tuesday, October 7th. Deutsche Bank Aktiengesellschaft lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price target on the stock. in a research note on Wednesday, October 29th. Finally, KeyCorp set a $405.00 price objective on shares of UnitedHealth Group in a report on Wednesday. One analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $380.67.

UnitedHealth Group Price Performance

UNH stock opened at $294.08 on Wednesday. UnitedHealth Group has a 52-week low of $234.60 and a 52-week high of $606.36. The business has a fifty day moving average of $331.78 and a two-hundred day moving average of $323.60. The stock has a market cap of $266.39 billion, a price-to-earnings ratio of 15.35, a price-to-earnings-growth ratio of 1.69 and a beta of 0.42. The company has a quick ratio of 0.82, a current ratio of 0.79 and a debt-to-equity ratio of 0.72.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, topping analysts’ consensus estimates of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The business had revenue of $113.22 billion during the quarter, compared to analysts’ expectations of $113.38 billion. During the same period in the prior year, the business posted $6.81 EPS. The company’s revenue was up 12.3% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. As a group, research analysts anticipate that UnitedHealth Group will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th were paid a $2.21 dividend. The ex-dividend date was Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a yield of 3.0%. UnitedHealth Group’s payout ratio is currently 46.14%.

Hedge Funds Weigh In On UnitedHealth Group

A number of large investors have recently modified their holdings of the business. Lebenthal Global Advisors LLC boosted its position in shares of UnitedHealth Group by 11.2% in the 4th quarter. Lebenthal Global Advisors LLC now owns 3,176 shares of the healthcare conglomerate’s stock worth $1,048,000 after buying an additional 319 shares in the last quarter. Diversified Enterprises LLC raised its holdings in UnitedHealth Group by 43.9% in the 4th quarter. Diversified Enterprises LLC now owns 4,744 shares of the healthcare conglomerate’s stock valued at $1,566,000 after acquiring an additional 1,448 shares during the last quarter. SP Asset Management LLC lifted its position in UnitedHealth Group by 90.4% during the fourth quarter. SP Asset Management LLC now owns 137,636 shares of the healthcare conglomerate’s stock worth $45,435,000 after buying an additional 65,334 shares during the period. Wealth Science Advisors LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth approximately $390,000. Finally, Quent Long Short Global Small Cap Fund LP acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at about $1,067,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Several major firms trimmed price targets but kept bullish ratings (buy/outperform), which helps stem the panic and supports a bounce as investors consider the pullback a buying opportunity. Analyst target changes
• Positive Sentiment: Media and retail-investor coverage framing the sell-off as a buy-the-dip moment (contrarian pieces and “bounce back” stories) is drawing short-term buying interest. Why UnitedHealth Group Stock Just Bounced Back
• Neutral Sentiment: Q4 results: UNH slightly beat EPS (driven by Optum Rx and other segments) but missed revenue by a small margin; management reiterated turnaround actions and provided FY2026 EPS guidance. This mixed fundamental print is keeping longer‑term investors evaluating the recovery timeline. Company press release
• Neutral Sentiment: Company guidance and commentary: Reuters and others note management expects 2026 adjusted profit roughly in line with or slightly above estimates while pursuing cost controls — a mixed signal for revenue growth vs. margin improvement. Reuters profit outlook
• Negative Sentiment: Regulatory shock: a Trump administration/CMS proposal to keep Medicare Advantage payments much lower than expected triggered the initial sharp sell-off — this directly pressures UNH’s Medicare business and drove the large multi‑day decline. Medicare rates story
• Negative Sentiment: Soft 2026 revenue guidance and one‑time charges: management flagged a roughly 2% revenue decline for 2026 (first in decades) and absorbed a ~$1.6B restructuring hit, which undermines near‑term earnings power and prompted analyst target cuts. Forbes analysis
• Negative Sentiment: Political scrutiny / insider trades: reports that some politicians sold UNH ahead of the crash have added reputational and regulatory uncertainty, intensifying the sell pressure while the story unfolds. Politician trades

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.